Trends in outpatient antibiotic prescribing practice among US older adults, 2011-2015: an observational study

Objective To identify temporal trends in outpatient antibiotic use and antibiotic prescribing practice among older adults. Design Observational study using United States Medicare administrative claims during 2011-2015. Trends in antibiotic use were estimated using multivariable regression adjusting for beneficiaries’ demographic and clinical covariates. Setting Medicare. Participants 4.6 million Medicare beneficiaries from a nationwide, 20% sample of fee-forservice Medicare beneficiaries ≥65 years old. Main outcome measurements Overall rates of antibiotic prescription claims, rates of appropriate and inappropriate prescribing, rates for each of the most frequently prescribed antibiotics, and rates of antibiotic claims associated with specific diagnoses. Results Antibiotic claims fell from 1362.2 to 1361.6 claims per 1,000 beneficiaries per year during 2011-2015, an overall 0.2% decrease (95% CI 0.07-0.32). Inappropriate antibiotic claims fell from 552 to 533 claims per 1,000 beneficiaries, a 4.1% decrease (CI 3.9-4.3). Individual antibiotics had heterogeneous changes in use. For example, azithromycin claims per beneficiary decreased by 18.4% (CI 18.2-18.7) while levofloxacin claims increased by 28.1% (CI 27.5-28.6). Azithromycin use associated with each of the potentially appropriate and inappropriate respiratory diagnoses we considered decreased, while levofloxacin use associated with each of those diagnoses increased. Conclusion Among US Medicare beneficiaries, overall antibiotic use and inappropriate use declined modestly, but individual drugs experienced divergent changes in use. Trends in drug use across indications were stronger than trends in use for individual indications, suggesting that guidelines and concerns about antibiotic resistance were not major drivers of change in antibiotic use.

[1]  V. Fraser,et al.  Outpatient Antibiotic Prescription Trends in the United States: A National Cohort Study , 2018, Infection Control & Hospital Epidemiology.

[2]  L. Davidson,et al.  Patient, Provider, and Practice Characteristics Associated with Inappropriate Antimicrobial Prescribing in Ambulatory Practices , 2018, Infection Control & Hospital Epidemiology.

[3]  G. Schumock,et al.  Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010–2015 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Linnea A. Polgreen,et al.  Phantom Prescribing: Examining the Frequency of Antimicrobial Prescriptions Without a Patient Visit , 2016, Infection Control & Hospital Epidemiology.

[5]  Prevalence of Inappropriate Antibiotic Prescriptions among US Ambulatory Care Visits, 2010-2011 , 2016 .

[6]  S. Schrag,et al.  US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Lisa G Winston,et al.  Burden of Clostridium difficile Infection in the United States , 2015 .

[8]  Bryan T Grenfell,et al.  Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. , 2014, The Lancet. Infectious diseases.

[9]  Grace C. Lee,et al.  Outpatient antibiotic prescribing in the United States: 2000 to 2010 , 2014, BMC Medicine.

[10]  Michael Lawrence Barnett,et al.  Antibiotic prescribing for adults with acute bronchitis in the United States, 1996-2010. , 2014, JAMA.

[11]  Daniel J. Shapiro,et al.  Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. , 2014, The Journal of antimicrobial chemotherapy.

[12]  Michael Lawrence Barnett,et al.  Antibiotic prescribing to adults with sore throat in the United States, 1997-2010. , 2014, JAMA internal medicine.

[13]  C Michael Stein,et al.  Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.

[14]  Sepheen C. Byron,et al.  Variation in outpatient antibiotic prescribing in the United States. , 2009, The American journal of managed care.

[15]  J. Levy,et al.  Adverse selection in the Medicare prescription drug program. , 2009, Health affairs.

[16]  Carlos G. Grijalva,et al.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. , 2009, JAMA.

[17]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Robert S. Dittus,et al.  Trends in antibiotic prescribing for adults in the United States—1995 to 2002 , 2005, Journal of General Internal Medicine.

[19]  J. Linder,et al.  Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999 , 2003, Annals of Internal Medicine.

[20]  J. Hughes,et al.  Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000 , 2003, Emerging infectious diseases.

[21]  Ralph Gonzales,et al.  Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999 , 2003, Annals of Internal Medicine.

[22]  M. Pichichero Dynamics of antibiotic prescribing for children. , 2002, JAMA.

[23]  F. Martinez,et al.  Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  D. Malone,et al.  Excessive antibiotic use for acute respiratory infections in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Burke Antibiotic resistance--squeezing the balloon? , 1998, JAMA.

[26]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[27]  J. Hughes,et al.  Trends in antimicrobial drug prescribing among office-based physicians in the United States. , 1995, JAMA.

[28]  H. White,et al.  Some heteroskedasticity-consistent covariance matrix estimators with improved finite sample properties☆ , 1985 .